Single-Cell and Spatial Transcriptomics Across Populations With Perianal Fistulizing Crohn's Disease Shows

Sushma C Maddipatla1, Sachith Munasinghe1, Anne Dodd1

  • 1Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.

Insights

Pro-inflammatory macrophages in Crohn's disease (CD) with fistulas show reduced phagocytic activity and form aggregates, impacting cellular networks. These changes are more pronounced in African Americans with fistulizing CD.

Area of Science:

  • Gastroenterology
  • Immunology
  • Cellular Biology

Background:

  • Perianal fistulizing Crohn's disease (CD) is a severe complication with higher prevalence in African Americans (AA) compared to European Americans (EA).
  • Understanding cellular and molecular differences in rectal CD with perianal fistulas is crucial for insights into disease severity and progression.

Purpose of the Study:

  • To define distinguishing cellular and molecular features between inflamed rectal CD with and without perianal fistulas.
  • To investigate population-level differences, particularly between AA and EA individuals, in fistulizing CD.

Main Methods:

  • Single cell sequencing of rectal mucosal biopsies from 50 individuals (18 CD with fistula, 25 CD without fistula, 7 controls).
  • Spatial transcriptomics (Sopa, Squidpy) and immunofluorescence (QuPath) analyses.
  • Rectal organoid models to assess inflammatory signaling.

Main Results:

  • Decreased phagocytic signature and antigen processing in CD4+CD68+ macrophages in fistulizing CD.
  • Pro-inflammatory macrophages formed aggregates in the lamina propria, disrupting cellular networks.
  • Significant differences in cellular pathways were observed between AA and EA individuals with fistulizing CD, and within the AA population based on fistula presence.

Conclusions:

  • CD4+ macrophages in inflamed rectal CD with fistula alter cellular networks and form aggregates.
  • These macrophages likely mediate complex interactions involved in fistula tract formation and progression.
  • Population-specific differences, especially in AA individuals, highlight potential disparities in disease mechanisms.
Abstract

Keywords:
Xxxx

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...